These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30834577)

  • 1. A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress.
    Saito S; Namisaki H; Hiraishi K; Takahashi N; Iida S
    Protein Sci; 2019 May; 28(5):900-909. PubMed ID: 30834577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a human IgG2 antibody stable at low pH.
    Saito S; Namisaki H; Hiraishi K; Takahashi N; Iida S
    Protein Sci; 2020 May; 29(5):1186-1195. PubMed ID: 32142185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R409K mutation prevents acid-induced aggregation of human IgG4.
    Namisaki H; Saito S; Hiraishi K; Haba T; Tanaka Y; Yoshida H; Iida S; Takahashi N
    PLoS One; 2020; 15(3):e0229027. PubMed ID: 32182240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities.
    Natsume A; In M; Takamura H; Nakagawa T; Shimizu Y; Kitajima K; Wakitani M; Ohta S; Satoh M; Shitara K; Niwa R
    Cancer Res; 2008 May; 68(10):3863-72. PubMed ID: 18483271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies.
    Bonagura VR; Artandi SE; Agostino N; Tao MH; Morrison SL
    DNA Cell Biol; 1992 Apr; 11(3):245-52. PubMed ID: 1567557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic interactions modulate the differential aggregation propensities of IgG1 and IgG4P antibodies and inform charged residue substitutions for improved developability.
    Heads JT; Lamb R; Kelm S; Adams R; Elliott P; Tyson K; Topia S; West S; Nan R; Turner A; Lawson ADG
    Protein Eng Des Sel; 2019 Dec; 32(6):277-288. PubMed ID: 31868219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
    Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.
    Niwa R; Natsume A; Uehara A; Wakitani M; Iida S; Uchida K; Satoh M; Shitara K
    J Immunol Methods; 2005 Nov; 306(1-2):151-60. PubMed ID: 16219319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain.
    Sakurai K; Nakahata R; Lee YH; Kardos J; Ikegami T; Goto Y
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1526-35. PubMed ID: 25748879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-native conformational states of immunoglobulins: thermodynamic and functional analysis of rabbit IgG].
    Vlasov AP; Kravchuk ZI; Martsev SP
    Biokhimiia; 1996 Feb; 61(2):212-35. PubMed ID: 8717493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
    Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
    Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.
    Li D; Gong R; Zheng J; Chen X; Dimitrov DS; Zhao Q
    Biochem Biophys Res Commun; 2017 Apr; 485(2):446-453. PubMed ID: 28202413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational implications of an inversed pH-dependent antibody aggregation.
    Perico N; Purtell J; Dillon TM; Ricci MS
    J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation.
    Gong Q; Hazen M; Marshall B; Crowell SR; Ou Q; Wong AW; Phung W; Vernes JM; Meng YG; Tejada M; Andersen D; Kelley RF
    MAbs; 2016; 8(6):1098-106. PubMed ID: 27216702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.